How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians

被引:14
|
作者
Sharma, Akanksha [1 ,2 ]
Fruth, Briant [3 ]
Barrera, Celina [4 ]
Farfour, Hannah N. [4 ]
Mrugala, Maciej M. [1 ]
Edwin, Mark K. [4 ]
Sloan, Jeff A. [3 ]
Porter, Alyx B. [1 ]
机构
[1] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA
[2] St John Canc Inst, Pacific Neurosci Inst, Dept Translat Neurosci, Santa Monica, CA 90404 USA
[3] Mayo Clin, Dept Biostat, Rochester, MN USA
[4] Mayo Clin, Dept Palliat Med, Phoenix, AZ USA
关键词
Glioblastoma; Glioma; Brain tumors; Prognosis; Quality of life; Terminal disease; Caregivers;
D O I
10.1007/s11060-021-03700-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Discordant prognostic awareness (PA) can cause distress, impact goals of care and future planning, especially in patients with high grade glioma (pwHGG) who have limited survival. We aimed to evaluate the feasibility of assessing PA of pwHGG, caregivers and clinicians using a single question and to evaluate these responses for discord, alignment and fluctuation over time. Methods This is a sub-study of an IRB-approved pilot study evaluating early palliative care and longitudinal symptom monitoring via a smart-device tool in 16 pwHGG and their caregivers receiving treatment at the Mayo Clinic Arizona (United States). Eligible patients were >= 18 years, English-speaking, newly-diagnosed, and had a willing caregiver. Participants answered a multiple-choice question asking for an estimate of their own or their loved one's survival on a monthly basis. Results All except one patient/caregiver dyad answered the question each time it was asked. The question did not appear to cause discomfort or increase conversations with clinicians around prognosis. PA of patients and caregivers fluctuated monthly, ranging from dismal to overtly optimistic, with a discordance frequency of 68%. Patients tended to be more optimistic than caregivers, and a higher QOL correlated to a more optimistic response. Clinicians' were more hopeful; their prediction tended to fluctuate less than those of patients and caregivers. Conclusions PA may be assessed in pwHGG and caregivers with a single, frank question. There is clear discordance between PA of patients, their caregivers and clinicians. Understanding fluctuates longitudinally through disease and treatment course. Additional studies on timing and ways of discussing prognosis in this population are needed.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 17 条
  • [1] How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians
    Akanksha Sharma
    Briant Fruth
    Celina Barrera
    Hannah N. Farfour
    Maciej M. Mrugala
    Mark K. Edwin
    Jeff A. Sloan
    Alyx B. Porter
    Journal of Neuro-Oncology, 2021, 152 : 313 - 323
  • [2] Longitudinal Perception of Prognosis of Patients with High Grade Glioma Compared to their Caregivers and Clinicians
    Sharma, Akanksha
    Wolfe, Eric
    Barrera, Celina
    Williamson, Samantha
    Farfour, Hannah
    Edwin, Mark
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 60 (01) : 297 - 298
  • [3] LONGITUDINAL PERCEPTION OF PROGNOSIS OF PATIENTS WITH HIGH GRADE GLIOMA COMPARED TO THEIR CAREGIVERS AND CLINICIANS
    Sharma, Akanksha
    Wolfe, Eric
    Barrera, Celina
    Williamson, Samantha
    Farfour, Hannah
    Mrugala, Maciej
    Edwin, Mark
    Sloan, Jeff
    Porter, Alyx
    NEURO-ONCOLOGY, 2019, 21 : 200 - 200
  • [4] Longitudinal Perception of Prognosis of Patients with High Grade Glioma Compared to their Caregivers and Clinicians
    Sharma, Akanksha
    Wolfe, Eric
    Barrera, Celina
    Williamson, Samantha
    Farfour, Hannah
    Mrugala, Maciej
    Edwin, Mark
    Sloan, Jeff
    Porter, Alyx
    NEUROLOGY, 2020, 94 (15)
  • [5] Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study
    Froklage, F. E.
    Oosterbaan, L. J.
    Sizoo, E. M.
    de Groot, M.
    Bosma, I.
    Sanchez, E.
    Douw, L.
    Heimans, J. J.
    Reijneveld, J. C.
    Lagerwaard, F. J.
    Buter, J.
    Uitdehaag, B. M. J.
    Klein, M.
    Postma, T. J.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 387 - 394
  • [6] Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study
    F. E. Froklage
    L. J. Oosterbaan
    E. M. Sizoo
    M. de Groot
    I. Bosma
    E. Sanchez
    L. Douw
    J. J. Heimans
    J. C. Reijneveld
    F. J. Lagerwaard
    J. Buter
    B. M. J. Uitdehaag
    M. Klein
    T. J. Postma
    Journal of Neuro-Oncology, 2014, 116 : 387 - 394
  • [7] CHEMORADIATION-INDUCED THROMBOCYTOPENIA IMPACTS MORBIDITY AND MORTALITY IN NEWLY-DIAGNOSED HIGH-GRADE GLIOMA PATIENTS
    Sumrall, Ashley L.
    Vredenburgh, James J.
    Desjardins, Annick
    Reardon, David A.
    Friiedman, Henry S.
    Peters, Katherine B.
    NEURO-ONCOLOGY, 2011, 13 : 53 - 53
  • [8] Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients
    Jiang, Shan
    Hill, Kala
    Patel, Dipen
    Waldeck, A. Reginald
    Botteman, Marc
    Aly, Abdalla
    Norden, Andrew D.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1237 - 1243
  • [9] A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors
    Michael B. Streiff
    Xiaobu Ye
    Thomas S. Kickler
    Serena Desideri
    Jayesh Jani
    Joy Fisher
    Stuart A. Grossman
    Journal of Neuro-Oncology, 2015, 124 : 299 - 305
  • [10] A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors
    Streiff, Michael B.
    Ye, Xiaobu
    Kickler, Thomas S.
    Desideri, Serena
    Jani, Jayesh
    Fisher, Joy
    Grossman, Stuart A.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (02) : 299 - 305